Alnylam Pharmaceuticals
ALNY
#757
Rank
โ‚ฌ29.11 B
Marketcap
217,56ย โ‚ฌ
Share price
0.43%
Change (1 day)
-43.77%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company